CSIMarket
 


United Cannabis Corp  (CNAB)
Other Ticker:  
 
    Sector  Healthcare    Industry Biotechnology & Drugs
   Industry Biotechnology & Drugs
   Sector  Healthcare
 

CNAB's Revenue Growth by Quarter and Year

United Cannabis's Revenue results by quarter and year




CNAB Revenue (in millions $) FY 2019 FY 2018 FY 2017 FY 2016
IV Quarter December - 2.98 -0.09 0.26
III Quarter September - 2.13 0.10 0.20
II Quarter June 3.96 1.86 0.16 0.25
I Quarter March 4.41 0.27 0.19 -
FY   8.37 7.24 0.36 0.71



CNAB Revenue second quarter 2019 Y/Y Growth Comment
United Cannabis Corp achieved in the second quarter, above Company average Revenue surge of 112.98% year on year, to $ 3.96 millions.

Looking into second quarter results within Biotechnology & Drugs industry 15 other companies have achieved higher Revenue growth. While United Cannabis Corp' s Revenue doubling of 112.98% ranks overall at the positon no. 188 in the second quarter.




CNAB Revenue ( Y/Y Growth %) 2019
2018 2017 2016
IV Quarter December - - - 100 %
III Quarter September - 2030 % -50 % -35.48 %
II Quarter June 112.98 % 1062.5 % -36 % 177.78 %
I Quarter March 1533.33 % 42.11 % - -
FY   - 1911.11 % -49.3 % -

Financial Statements
United Cannabis's second quarter 2019 Revenue $ 3.96 millions CNAB's Income Statement
United Cannabis's second quarter 2018 Revenue $ 1.86 millions Quarterly CNAB's Income Statement
New: More CNAB's historic Revenue Growth >>


CNAB Revenue (Quarter on Quarter Growth %)

2019
2018 2017 2016
IV Quarter December - 39.91 % - 30 %
III Quarter September - 14.52 % -37.5 % -20 %
II Quarter June -10.17 % 588.89 % -15.79 % -
I Quarter March 47.99 % - -26.92 % -
FY (Year on Year)   - 1911.11 % -49.3 % -




Revenue second quarter 2019 Y/Y Growth Company Ranking
Within: No.
Biotechnology & Drugs Industry #16
Healthcare Sector #55
Overall #188

Revenue Y/Y Growth Statistics
High Average Low
386.79 % 108.75 % 18.43 %
(Jun 30 2018)   (Jun 30 2019)
Revenue second quarter 2019 Y/Y Growth Company Ranking
Within: No.
Biotechnology & Drugs Industry #16
Healthcare Sector #55
Overall #188
Revenue Y/Y Growth Statistics
High Average Low
386.79 % 108.75 % 18.43 %
(Jun 30 2018)   (Jun 30 2019)

Revenue by Quarter for the Fiscal Years 2016, 2017, 2018, 2019

United Cannabis's Q/Q Revenue Growth


Revenue Q/Q Growth Statistics
High Average Low
599.21 % 53.45 % -100 %
(Jun 30 2018)  


CNAB's II. Quarter Q/Q Revenue Comment
In the II. Quarter 2019 United Cannabis Corp realized drop in Revenue sequentially by -10.17% to $ 3.96 millions, from $ 4.41 millions declared in the previous qaurter.

Those seasonal factors which commonly energize II. Quarter 2019 performance, have not salvage the II. Quarter for the United Cannabis Corp, Austin G. Adams, Biotechnology & Drugs industry contributor pointed out, he cited some caution conserning United Cannabis's direction.

Within Biotechnology & Drugs industry 64 other companies have achieved higher Revenue quarter on quarter growth. While United Cannabis's Revenue growth quarter on quarter, overall rank is 2687.


Revenue Q/Q Growth Company Ranking
Within: No.
Biotechnology & Drugs Industry #65
Healthcare Sector #367
Overall #2687
Revenue Q/Q Growth Company Ranking
Within: No.
Biotechnology & Drugs Industry #65
Healthcare Sector #367
Overall #2687
Revenue Q/Q Growth Statistics
High Average Low
599.21 % 53.45 % -100 %
(Jun 30 2018)  


CNAB's II. Quarter Q/Q Revenue Comment
In the II. Quarter 2019 United Cannabis Corp realized drop in Revenue sequentially by -10.17% to $ 3.96 millions, from $ 4.41 millions achived in the previous qaurter.

Even seasonal influence which commonly fuel II. Quarter 2019 Revenue, could not salvage the II. Quarter for the United Cannabis Corp, Austin G. Adams, Biotechnology & Drugs industry contributor pointed out, he sees further difficulties ahead for CNAB.

Within Biotechnology & Drugs industry 64 other companies have achieved higher Revenue quarter on quarter growth. While United Cannabis's Revenue growth quarter on quarter, overall rank is 2687.


United Cannabis's 12 Months Revenue Growth Year on Year


Revenue TTM Growth

12 Months Ending
(Jun 30 2019)
12 Months Ending
(Mar 31 2019)
12 Months Ending
(Dec 31 2018)
12 Months Ending
(Sep 30 2018)
12 Months Ending
(Jun 30 2018)
Cumulative Revenue 12 Months Ending $ 13.49 $ 11.39 $ 7.24 $ 4.17 $ 2.14
Y / Y Revenue Growth (TTM) 531.39 % 2495.16 % 1899.49 % 477.5 % 161.81 %
Year on Year Revenue Growth Overall Ranking # 28 # 15 # 149 # 54 # 123
Seqeuential Revenue Change (TTM) 18.43 % 57.23 % 73.89 % 94.99 % 386.79 %
Seq. Revenue Growth (TTM) Overall Ranking # 216 # 62 # 11 # 16 # 8




Cumulative Revenue growth Comment
With the quarterly Revenue reported in the Jun 30 2019 period, United Cannabis's cumulative twelve months Revenue were $ 13 millions, company would post below average annual Revenue growth of 386.79% year on year, if the fiscal year would end at Jun 30 2019.
A slow-down in the United Cannabis's Revenue growth from the 4.41% growth in Mar 31 2019.

Among companies within the Healthcare sector 8 other companies have achieved higher trailing twelve month Revenue growth. While Revenue growth total ranking has deteriorated compare to previous quarter from 15 to 28.

Revenue TTM Q/Q Growth Statistics
High Average Low
386.79 %
108.75 %
18.43 %
 

Revenue TTM Y/Y Growth Company Ranking
Within: No.
Biotechnology & Drugs Industry # 18
Healthcare Sector # 9
Overall # 28

Revenue TTM Y/Y Growth Statistics
High Average Low
2495.16 %
919.04 %
-51.09 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 18
Sector # 59
S&P 500 # 216
Cumulative Revenue growth Comment
With the quarterly Revenue reported in the Jun 30 2019 period, United Cannabis's cumulative twelve months Revenue were $ 13 millions, company would post below average annual Revenue growth of -51.09% year on year, if the fiscal year would end at Jun 30 2019.
A slow-down in the United Cannabis's Revenue growth from the 4.41% growth in Mar 31 2019.

Among companies within the Healthcare sector 8 other companies have achieved higher trailing twelve month Revenue growth. While Revenue growth total ranking has deteriorated compare to previous quarter from 15 to 28.

Revenue TTM Q/Q Growth Statistics
High Average Low
386.79 %
108.75 %
18.43 %
 


Revenue TTM Y/Y Growth Company Ranking
Within: No.
Biotechnology & Drugs Industry # 18
Healthcare Sector # 9
Overall # 28

Revenue TTM Y/Y Growth Statistics
High Average Low
2495.16 %
919.04 %
-51.09 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 18
Sector # 59
S&P 500 # 216




Other Revenue Growth
Biotechnology & Drugs Industry Revenue Growth Trends and Statistics
Healthcare Sector Revenue Growth Statistics
Revenue Growth Trends for overall market
CNAB's Revenue Growth Ratio versus Biotechnology & Drugs Industry, Healthcare Sector and total Market
Highest Ranking Revenue Growth
Lowest Ranking Revenue Growth
Revenue Growth for CNAB's Competitors
Revenue Growth for United Cannabis's Suppliers
Revenue Growth for CNAB's Customers

You may also want to know
CNAB's Annual Growth Rates CNAB's Profitability Ratios CNAB's Asset Turnover Ratio CNAB's Dividend Growth
CNAB's Roe CNAB's Valuation Ratios CNAB's Financial Strength Ratios CNAB's Dividend Payout Ratio
CNAB's Roa CNAB's Inventory Turnover Ratio CNAB's Growth Rates CNAB's Dividend Comparisons



Companies with similar Revenue drop for the quarter ending Jun 30 2019 within Healthcare SectorY/Y Change %Revenue for the quarter ending Jun 30 2019
Zyla Life Sciences  196.04 %$ 196.037 millions
Corindus Vascular Robotics, Inc.  174.77 %$ 174.775 millions
Vbi Vaccines Inc  173.50 %$ 173.504 millions
Tandem Diabetes Care, Inc.  173.27 %$ 173.267 millions
Seres Therapeutics, Inc.  171.70 %$ 171.704 millions
Progenics Pharmaceuticals Inc  156.99 %$ 156.988 millions
Denali Therapeutics Inc.  154.67 %$ 154.672 millions
Biodelivery Sciences International Inc  143.75 %$ 143.754 millions
Amarillo Biosciences Inc  142.40 %$ 142.400 millions
Catasys, Inc.  134.68 %$ 134.678 millions
Geovax Labs, Inc.  125.10 %$ 125.102 millions
Tivity Health, Inc.  124.13 %$ 124.131 millions
Cesca Therapeutics Inc.  114.82 %$ 114.820 millions
Healthlynked Corp  113.38 %$ 113.376 millions
United Cannabis Corp  112.77 %$ 112.773 millions
Heron Therapeutics, Inc.  112.18 %$ 112.184 millions
Pulse Biosciences, Inc.  111.68 %$ 111.679 millions
Northwest Biotherapeutics Inc  108.99 %$ 108.993 millions
Amicus Therapeutics, Inc.  107.10 %$ 107.096 millions
Akebia Therapeutics, Inc.  106.59 %$ 106.593 millions
Antares Pharma, Inc.  100.77 %$ 100.770 millions
Exact Sciences Corp  94.25 %$ 94.248 millions
Jaguar Health, Inc.  92.99 %$ 92.985 millions
Athenex, Inc.  91.93 %$ 91.933 millions
Amarin Corp Plcuk  91.46 %$ 91.463 millions
Neurocrine Biosciences Inc  89.44 %$ 89.443 millions
Ultragenyx Pharmaceutical Inc.  88.75 %$ 88.753 millions
Unum Therapeutics Inc.  88.36 %$ 88.355 millions
Aduro Biotech, Inc.  85.22 %$ 85.222 millions
Cerus Corp  83.57 %$ 83.573 millions


             
Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

ROX's Profile

Stock Price

ROX's Financials

Business Description

Fundamentals

Charts & Quotes

ROX's News

Suppliers

ROX's Competitors

Customers & Markets

Economic Indicators

ROX's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Largest Companies

Management Effectivness

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Indices

Sectors & Industries

Financials

Commodities

Currencies

News


At a Glance

Stocks

Economy

Industries

Other

Help


Sitemap

Advertise

About us

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.  Free Stock Market News Feeds
   Copyright © 2019 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

To view Intraday Stock Data Java must be installed. Java content may be prohibited by the security software, to see the stock quotes, choose "allow content from this page" option. Stock Price, historical and current end-of-day data provided by eoddata. Intraday data delayed per exchange requirements. S&P/Dow Jones Indices (SM) from Barchart and Eoddata. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071